Sosei teams up with Abbvie on neurological drug discovery
Drug Discovery World
AUGUST 4, 2022
Biopharmaceutical group Sosei will work together with AbbVie on a drug discovery project to discover, develop and commercialise small molecules that target neurological diseases. . Abbvie has the option to license three programmes at this stage and if so, will be responsible for clinical,? regulatory ?and
130 
Let's personalize your content